NATCO Pharma Ltd. logo

NATCO Pharma Ltd. share price

NSE: NATCOPHARM · Healthcare

₹828.65 +2.25%

Closing price data, updated 17 Nov 2026. 52-week range: -32.5% from high, +7.1% above low.

Price₹828.65
Market cap₹14,963 Cr
P/E13.1
P/B1.62
ROE16.9%
ROCE16.1%
Debt / equity0.08
Dividend yield0.00%
EPS₹63.37
Book value₹510.67
Operating margin31.1%
Dipscan score63 / 100
Open full analysis, charts & financials →

Share: WhatsAppX / TwitterTelegram

NATCO Pharma Ltd. shareholding pattern

As of Sep 2026: Promoters 49.39%, FIIs 16.00%, DIIs 6.16%, Government 0.00%, Public 23.85%, Others 4.60%.

HolderSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025
Promoters49.39%49.42%49.42%49.48%49.48%49.56%
FIIs16.00%16.99%17.37%15.16%14.09%15.51%
DIIs6.16%5.62%5.46%5.39%5.87%5.82%
Government0.00%0.00%0.00%0.00%0.00%0.00%
Public23.85%23.41%23.34%25.38%25.84%25.22%
Others4.60%4.56%4.41%4.58%4.72%3.89%
No. of Shareholders404,135403,166410,970424,167419,699429,434

As filed by the company with the exchanges.

Returns

1 day1 week1 month3 months6 months1 year
+2.25%+2.68%+5.88%-12.93%-31.20%+4.50%

Growth

Sales growth, 3 years+14.5%
Sales growth, 5 years–
Profit growth, 3 years+25.6%
Profit growth, 5 years–
Latest quarter sales vs last year-44.7%
Latest quarter profit vs last year-57.0%

Strengths and weaknesses

Strengths

Weaknesses

Peers in Healthcare

CompanyPriceMarket capP/EROE1 year
Sun Pharmaceutical Industries ₹1,867.50₹4,48,076 Cr40.914.7%+8.8%
Divi's Laboratories Ltd.₹11,080.00₹2,94,139 Cr87.516.2%+69.4%
Torrent Pharmaceuticals Ltd.₹4,691.20₹1,78,438 Cr84.027.1%+22.6%
Apollo Hospitals Enterprise Lt₹8,771.00₹1,26,114 Cr56.221.9%+16.9%
Laurus Labs Ltd.₹2,220.00₹1,19,949 Cr89.518.2%+125.2%
Zydus Lifesciences Ltd.₹1,192.00₹1,18,902 Cr28.419.7%+27.0%
Dr. Reddy's Laboratories Ltd.₹1,377.90₹1,14,778 Cr41.012.1%+13.7%
Cipla Ltd.₹1,394.50₹1,12,658 Cr38.911.8%-8.0%

Frequently asked questions

What is the share price of NATCO Pharma Ltd.?

NATCO Pharma Ltd. (NATCOPHARM) last closed at ₹828.65 (+2.25% on the day).

What is the market cap of NATCO Pharma Ltd.?

About ₹14,963 Cr.

What is the P/E ratio of NATCO Pharma Ltd.?

The price-to-earnings ratio is 13.1, and return on equity is 16.9%.

Figures are calculated from company results and exchange prices and are for information only.